chr16-50630887-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_033119.5(NKD1):c.672G>T(p.Glu224Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,603,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033119.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NKD1 | NM_033119.5 | c.672G>T | p.Glu224Asp | missense_variant | 8/10 | ENST00000268459.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NKD1 | ENST00000268459.6 | c.672G>T | p.Glu224Asp | missense_variant | 8/10 | 1 | NM_033119.5 | P1 | |
NKD1 | ENST00000566396.1 | n.566G>T | non_coding_transcript_exon_variant | 3/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000571 AC: 13AN: 227820Hom.: 0 AF XY: 0.0000489 AC XY: 6AN XY: 122704
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1450876Hom.: 0 Cov.: 30 AF XY: 0.0000111 AC XY: 8AN XY: 720306
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 09, 2022 | The c.672G>T (p.E224D) alteration is located in exon 8 (coding exon 8) of the NKD1 gene. This alteration results from a G to T substitution at nucleotide position 672, causing the glutamic acid (E) at amino acid position 224 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at